» Articles » PMID: 1186921

Effect of Nafenopin (SU-13,437) on Liver Function: Mechanism of Choleretic Effect

Overview
Specialty Pharmacology
Date 1975 Sep 24
PMID 1186921
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Administration of nafenopin (SU-13-437) to male rats for two days leads to a doubling of bile production and a 50% increase in liver weight. These two effects have been shown not to be directly interrelated. A marked decrease in biliary salt concentration suggests that the bile salt independent flow is stimulated. The extra bile produced is probably of canalicular origin since bile to plasma concentration ratios of erythritol are unchanged. At least three polar metabolites of nafenopin have been observed in rat bile. Observations in rats with partial biliary fistulas indicate that the drug and its metabolites undergo extensive entero-hepatic circulation. Our studies support the view that much of the enhanced bile flow is associated with the presence of nafenopin and/or its metabolites within the hepatobiliary system. However, the response is too extensive to be explained merely by osmotic choleresis. Induced structural changes in the liver may also account forsome of this effect.

Citing Articles

Effect of nafenopin (SU-13,437) on liver function: influence on the hepatic transport of organic anions.

Meijer D, Bognacki J, Levine W Naunyn Schmiedebergs Arch Pharmacol. 1975; 290(2-3):235-50.

PMID: 810733 DOI: 10.1007/BF00510553.


Bile formation and biliary lipid composition under the influence of clofibrate and phenobarbital pretreatment in the rat.

Kutz K, Schulte A, Just C, Lindstaedt H, Reiter B Naunyn Schmiedebergs Arch Pharmacol. 1979; 308(2):171-7.

PMID: 503248 DOI: 10.1007/BF00499061.

References
1.
Paumgartner G, HORAK W, Probst P, Grabner G . Effect of phenobarbital on bile flow and bile salt excretion in the rat. Naunyn Schmiedebergs Arch Pharmakol. 1971; 270(1):98-101. DOI: 10.1007/BF00997305. View

2.
Meijer D, Bognacki J, Levine W . Effect of nafenopin (SU-13,437) on liver functions. Hepatic uptake and biliary excretion of ouabain in the rat. Drug Metab Dispos. 1975; 3(3):220-5. View

3.
Gunter M, Kim K, Magee D, RALSTON H, IVY A . The choleretic potencies of some synthetic compounds. J Pharmacol Exp Ther. 1950; 99(4:1):465-78. View

4.
Reddy J, Svoboda D, Azarnoff D . Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB. Biochem Biophys Res Commun. 1973; 52(2):537-43. DOI: 10.1016/0006-291x(73)90745-6. View

5.
Berthelot P, Erlinger S, Dhumeaux D, Preaux A . Mechanism of phenobarbital-induced hypercholeresis in the rat. Am J Physiol. 1970; 219(3):809-13. DOI: 10.1152/ajplegacy.1970.219.3.809. View